Zdrowie i gospodarka · 11/02/2004

FDA Approves New Animal Drug for Skeletal Marking of Finfish Fry and Fingerlings

The US Food and Drug Administration (FDA) has amended its animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Alpharma, Inc. for oxytetracycline hydrochloride soluble powder, which will be used for skeletal marking of finfish fry and fingerlings by immersion.